Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


‘Buy American’ Exec Order Presses Government To Only Purchase US-Made Devices, Drugs

Order would be in place primarily during public health emergencies, including COVID-19 pandemic

Executive Summary

Medical countermeasures such as devices and drugs used for COVID-19 could only be purchased from domestic manufacturers under a new executive order.

You may also be interested in...

Ventilators, Infusion Pumps, PPE, And More: 96 Devices Make FDA’s Critical Medical Products List

The US FDA’s list of essential products for use during infectious diseases outbreaks and other public health threats comes almost three months after President Trump signed an executive order directing the agency to develop one.

Key Lawmakers Press US Trade Commissioner On Barriers To Device Supply Chain

The chairs of the House Ways and Means and Senate Finance committees are asking the US International Trade Commission to look into COVID-19 medtech supply chain barriers.

COVID-19: AdvaMed Asks USTR To Drop Tariffs On More Chinese Medtech Products

The largest medtech industry group has asked the Office of the US Trade Representative to waive tariffs on more medical devices imported from China as the US fights the COVID-19 crisis. AdvaMed wants an indefinite waiver, or at least one that extends a year beyond when the WHO declares an end to the pandemic.


Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts